compounded semaglutide heartburn FDA Warns on Certain Forms of Heartburn & Semaglutide: Safe Antacid

MHRA and EMA include thyroid warnings in product information

Blood pressure-related effects (low blood pressure, episodes of loss of consciousness), highlighting the need for careful monitoring

Side effects scale with potency

Exceptions exist for patients with documented allergies to specific inactive ingredients in brand-name products

MHRA-licensed options include semaglutide (Wegovy), liraglutide (Saxenda), orlistat, and tirzepatide (Mounjaro)

No unexpected safety issues have arisen to date, and the established safety profile for semaglutide is similar to that of other GLP-1RAs where definitive conclusions for pancreatic and thyroid cancer cannot be drawn at this point due to low incidence of these conditions